NRC Health Common Stock
NRC
115 hedge funds and large institutions have $414M invested in NRC Health Common Stock in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
5% more funds holding
Funds holding: 110 → 115 (+5)
2% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 43
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.28% less ownership
Funds ownership: 47.11% → 44.83% (-2.3%)
11% less capital invested
Capital invested by funds: $465M → $414M (-$50.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$36.8M |
| 2 |
BlackRock
New York
|
+$2.11M |
| 3 |
Bank of New York Mellon
New York
|
+$1.41M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$718K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$638K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$2.39M |
| 2 |
Renaissance Technologies
New York
|
-$1.08M |
| 3 |
APC
Alpine Peaks Capital
New York
|
-$718K |
| 4 |
NEI
Northwest & Ethical Investments
Toronto,
Ontario, Canada
|
-$596K |
| 5 |
QI
QV Investors
Calgary,
Alberta, Canada
|
-$559K |
NRC Hedge Fund Activity: Q4 2022 in Review
115 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q4 2022, worth a combined $414M — down 11% from $465M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NRC positions and 4 closed out — a net gain of 8 holders — while 44 added to existing stakes and 43 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $36.8M. The largest seller was Mawer Investment Management, exiting entirely with an estimated $2.39M sold.
- 115 institutional investors held NRC Health Common Stock (NRC) as of Q4 2022, up from 110 in Q3 2022.
- Funds reported $414M of NRC Health Common Stock stock for Q4 2022, down 11% quarter-over-quarter.
- 12 funds opened new NRC Health Common Stock positions in Q4 2022 and 4 closed out, a net change of +8 holders.
- The largest NRC Health Common Stock buyer in Q4 2022 was Morgan Stanley, an estimated $36.8M added.
- The largest NRC Health Common Stock seller in Q4 2022 was Mawer Investment Management, an estimated $2.39M sold.
Based on aggregated 13F filings for Q4 2022.